Cancer Research KI

Cancer Research KI will elect the director and two (2) members to the CRKI Executive board during autumn 2023 and the CRKI Nomination Committee hereby open the call for nominations.

Congratulations to the receivers of KI- Mayo Collaborative grant - 2023! 

The launch of a new European consortium, funded with 6 million Euro, to create a network of support for EU Mission on Cancer. 

Sweden is represented by Karolinska CCC (Karolinska Institutet and Karolinska University Hospital), Zero Vision Cancer and SALAR  which will collaborate closely with the consortium coordinators (AICIB) and leading experts across Europe, to establish a National Cancer Mission Hub in our country. 

Karolinska Institutet and Cancer Research UK’s innovation engine, Cancer Research Horizons, have announced a 5-year strategic partnership dedicated to accelerating the translation of academic cancer research into improved treatments for patients.

Here is a short recap from the latest Scientific Advisory Board (SAB), visit to Karolinska CCC on May 15-16th, 2023. 

Applications are open for Cancer Core Europe (CCE) Summer School in Translational Cancer Research, taking place in beautiful Algarve, Portugal, October 8-14, 2023. Find out more about topics and confirmed speakers, and register for this event latest by May 31st, 2023.

Date and Time: 9th of May (10:30-15:00)

Location: Karolinska University Hospital, Solna, Sune Bergström Aula

The conference will address the advantages and challenges that the EU and its citizens meet related to cancer care and to discuss how to develop them further. The purpose of the event is to contribute to the further development of implementation of Europe’s Beating Cancer Plan.

European collaboration enhances cross-learning between healthcare and research – and raises hopes for cancer patients

Latest updates from Cancer Core Europe 2023 annual meeting 

Time and date: June 22, 2023, 8:00–11:30 US CT / 3:00–6:30 CET, Online via Zoom

Cancer Research KI hereby announces up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle.  

Welcome to a lecture by this year's Sjöberg Laureate chemist Kevan M. Shokat from the USA. Ten years ago, he became the first person to succeed in blocking one of the mutated proteins that cause most cancer cases. This is a huge scientific breakthrough that is bringing hope to people who are critically ill with lung cancer.

The Mayo Clinic Comprehensive Cancer Center and Karolinska Institutet are pleased to announce the 2023 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of March 31, 2023.

Registration has been prolonged until 24th of March.

Please check out the interview with Klas Wiman och Galina Selivanova for Radiumhemmets Forskningsfonder.

Photo: Gonzalo Irigoyen for Radiumhemmets Forskningsfonder.

Radiumhemmets forskningsfonder interview with Martin Enge, PhD from the Dept. of Oncology-Pathology KI.

(text in Swedish)

In Autumn 2022, Cancer Research KI will elect three or four (3-4) members to the CRKI Executive board and the CRKI Nomination Committee hereby open the call for nominations.

Deadline: September 15th, 2022

The Mayo Clinic Cancer Center and Cancer Research K are pleased to announce the 2022 recipients of the collaborative grants supporting Breast Cancer, other Solid Tumors, and Hematologic Malignancies research.

The bridging grant provide two-year funding at the consolidator level to the highest ranked applicant who was not awarded the KI five-year consolidator grant (1.2 million SEK per year, for 2022-2023). The Bridging grant recipient is  Linda Lindström, Associate Professor in Cancer Epidemiology and Group Leader at the Department of Oncology and Pathology.

Anna Martling (Precision Medicine Centre Karolinska (PMCK)) and Hans-Gustaf Ljunggren (NextGenNK) in an article in the Swedish newspapper Dagens Industri. Article in Swedish. 

Cancer Research KI has mapped the research landscape at KI and created a database with information about research groups across KI that conduct cancer research. The database is intended for researchers at KI and elsewhere as well as others interested in obtaining an overview of cancer research at KI, to foster new collaborations, learn more about specific cancer areas, or explore industrial interactions.

The Registration for the Summer School in Cancer Immunotherapy is now open for PhD students and post-doctoral fellows at Karolinska Institutet.

Deadline for registration: August 3 .

On the 15th of June the partnership launch event will take place in Innomdicum auditorium Daggkåpan at Nanna Svartz väg 4. The event will start at 8.30 with networking and end at 12.00. Read more about the event and register here. 

Time and date: June 22, 2023, 8:00–11:30 US CT / 3:00–6:30 CET, Online via Zoom

Welcome to the seminar organised by Cancer Research KI.

Date and time: 23rd of March

Title: How to collaborate with academia the company perspective

Venue: Inghesalen, Tomtebodavägen 18a

Please join us to listen to several companies that have experience from both collaborating with academia as well as has sprung out of academia. Programme and registration will be published soon.

In collaboration with  RCC Stockholm-Gotland, Cancer Research KI, organises a digital workshop in cancer for patient organisations. The workshop is in Swedish and gives opportunities for interaction and communication between cancer patient organisations and researchers.   

Researchers at King’s College London (KCL) and Karolinska Institutet (KI) are collaborating in organising a course entitled Clinical cancer epidemiology: From prevention to treatment and patient care, over 5 days from June till December 2023.